CoChat

A new hERG allosteric modulator rescues genetic and drug‐induced long‐ QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells

Open access
Sala, Luca, Yu, Zhiyi, Ward‐van Oostwaard, Dorien, van Veldhoven, Jacobus PD, Moretti, Alessandra, Laugwitz, Karl‐Ludwig, Mummery, Christine L, IJzerman, Adriaan P, Bellin, Milena · 2016 · EMBO Molecular Medicine
Cited by 87

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Long‐ QT syndrome ( LQTS ) is an arrhythmogenic disorder characterised by prolongation of the QT interval in the electrocardiogram, which can lead to sudden cardiac death. Pharmacological treatments are far from optimal for congenital forms of LQTS , while the acquired form, often triggered by drugs that (sometimes inadvertently) target the cardiac hERG channel, is still a challenge in drug development because of cardiotoxicity. Current experimental models in vitro fall short in predicting proarrhythmic properties of new drugs in humans. Here, we leveraged a series of isogenically matched, diseased and genetically engineered, human induced pluripotent stem cell‐derived cardiomyocytes (hi PSC ‐ CM s) from patients to test a novel hERG allosteric modulator for treating congenital LQTS , drug‐induced LQTS or a combination of the two. By slowing I K r deactivation and positively shifting I K r inactivation, the small molecule LUF 7346 effectively rescued all of these conditions, demonstrating in a human system that allosteric modulation of hERG may be useful as an approach to treat inherited and drug‐induced LQTS . Furthermore, our study provides experimental support of the value of isogenic pairs of patient hi PSC ‐ CM s as platforms for testing drug sensitivities and performing safety pharmacology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/emmm.201606260

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 87

Metadata

Authors
Sala, L., Yu, Z., Ward‐van Oostwaard, D., van Veldhoven, J. P., Moretti, A., Laugwitz, K., Mummery, C. L., IJzerman, A. P., & Bellin, M.
Venue
EMBO Molecular Medicine
Published
2016-07-28
Volume
8
Issue
9
Pages
1065-1081
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W2501001405
Cited by
87
References
3
FWCI
11.21
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A new hERG allosteric modulator rescues genetic and drug‐induced long‐ QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells. https://app.cochat.ai/papers/10.15252/emmm.201606260
The paper
Sala, L., Yu, Z., Ward‐van Oostwaard, D., van Veldhoven, J. P., Moretti, A., Laugwitz, K., Mummery, C. L., IJzerman, A. P., & Bellin, M. (2016). A new hERG allosteric modulator rescues genetic and drug‐induced long‐ QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.201606260

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.